Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Silvercrest Asset Management Group Financial Results
Silvercrest Asset Management Group reported Q3 2026 results, with discretionary assets under management (AUM) decreasing to $23.8 billion primarily due to weaker market conditions. The company highlighted a 2% year-over-year increase in year-to-date revenue and the receipt of a full MiFID license through the Central Bank of Ireland to expand its European operations.
Asure Software reported Q3 2026 revenue of $40.0 million, a 10% increase year-over-year, driven by a 16% rise in recurring revenue. The company significantly narrowed its net loss to $0.6 million and improved its Adjusted EBITDA to $10.5 million. Subsequent to the quarter, Asure secured a new $115 million credit facility and completed a $26.5 million acquisition of a payroll processing business.
Term
Q3 2026
“We delivered solid growth in the third quarter, with revenue increasing 10% year-over-year to $40.0 million and recurring revenue up 16% versus the prior year, also we experienced a notable uplift in gross margins, as well as improved profitability.”
TEN Holdings adjourned its 2026 Annual Meeting of Stockholders due to the absence of a quorum. The meeting is scheduled to reconvene on November 12, 2026, to vote on director elections and the ratification of the company's independent auditor.
Boston Omaha Divestiture to CopperPoint Insurance Company for $84.3M
Boston Omaha Corporation completed the sale of its General Indemnity Group (GIG) business unit to CopperPoint Insurance Company for a gross purchase price of approximately $84.3 million. As part of the transaction, Boston Omaha received $75.3 million in net cash proceeds at closing and the return of 2,673,831 shares of Sky Harbour Class A common stock previously held by the subsidiary.
Immuneering Corp is a late-stage clinical oncology company focused on developing its lead candidate, atebimetinib (IMM-1-104), for first-line pancreatic cancer. The company reports a history of significant net losses and expects to require substantial additional capital to fund its ongoing Phase 1/2a and MAPKeeper 301 registrational trials.
Beta Bionics Chief Product Officer Mike Mensinger Sells $58.3K of Stock
Mike Mensinger, Chief Product Officer, sold 2,650 shares of Beta Bionics, Inc. at $22.00 a share, worth $58.3K in total on Oct 27, 2026. Shares held after the trade: 174,740 (-1.5%).
Asure Software reported total revenue of $119.9 million for the nine months ended September 30, 2026, a 18% increase compared to the prior year. Despite the revenue growth, the company recorded a net loss of $4.4 million for the period, though this was a significant improvement from the $13.9 million net loss in the same period of 2025.
Alphatec Holdings reported Q3 2026 total revenue of $221 million, a 13% increase year-over-year, driven by 17% growth in surgical hardware revenue. Despite strong case volume growth of 20%, the company lowered its full-year 2026 revenue guidance to $862 million due to lower-than-expected biologics attachment.
Term
Q3 2026
“Third-quarter revenue fell short of our expectations, primarily due to lower biologics attachment. We own and are addressing that shortfall, and going forward, improving biologics performance is a clear priority for us. At the same time, we continued to see very strong demand for our procedural solutions, with hardware revenue growing 17%, case volumes growing approximately 20%, and new surgeon adoption increasing 25%.”
Covista Inc. reported revenue of $511.5 million for the quarter ended September 30, 2026, a 10.7% increase year-over-year, while net income rose to $67.4 million. The company significantly reduced its long-term debt by $163 million during the period and continued its aggressive share repurchase program, spending $81 million on treasury stock.
CNO Financial Group reported Q3 2026 net operating income of $179.1 million, or $1.90 per diluted share, representing a 47% increase in operating EPS year-over-year. The company raised its full-year 2026 operating EPS guidance midpoint by 9% following its 17th consecutive quarter of sales growth and a successful reinsurance transaction with its Bermuda affiliate.
Term
Q3 2026
“CNO delivered an excellent quarter, with operating earnings per share up 47% and our 17th consecutive quarter of sales growth. Our momentum reflects disciplined execution across the business and continued improvement in profitability.”
Gary C. Bhojwani, chief executive officer
“Based on these results, we are raising our full-year operating earnings per share guidance. We also executed our 3rd reinsurance transaction with our Bermuda affiliate, supporting our focus on serving middle-income households.”
Innovex International reported Q3 2026 revenue of $265 million, an 8% increase quarter-over-quarter, driven by growth in U.S. Land activity and subsea contract wins. The company maintained a strong balance sheet with $189 million in cash and no bank debt while generating $32 million in free cash flow.
Term
Q3 2026
“We delivered a strong third quarter as the investments we have made in our technology portfolio and global operating platform continue to drive profitable growth. Our U.S. Land business benefited from increased activity and modest share gains—with particular success in our cementing tool business.”
Adam Anderson, CEO
“Our third quarter results demonstrate the strength of Innovex's capital-light business model and disciplined approach to capital allocation. We generated $39 million of net cash provided by operating activities, $32 million of Free Cash Flow and ended the quarter with $189 million of cash and cash equivalents and no bank debt, providing significant financial flexibility to pursue both organic and inorganic growth opportunities.”
World Kinect Corporation reported Q3 2026 financial results with revenue of $13.27 billion and adjusted EPS of $0.99, significantly beating the prior year's performance. Driven by strong execution in the Marine and Aviation segments, the company raised its full-year 2026 adjusted EPS guidance to a range of $3.52 to $3.62.
Term
Q3 2026
“We delivered another strong quarter, supported by healthy fundamentals in Aviation, strong performance in Marine and continued progress in Land. The actions we have taken to reshape the company are creating a stronger, more focused business, better positioned to deliver improved returns and profitable growth.”
Ira M. Birns, Chief Executive Officer
“Our third quarter results reflect strong execution across the business and continued improvement in Land. We generated $164 million of free cash flow during the quarter, further strengthening our financial flexibility to invest in the business and return capital to shareholders.”
Mike Tejada, Executive Vice President and Chief Financial Officer
Cadiz Inc. entered into a placement agent agreement for a registered direct offering of 5,000,000 shares of common stock at $4.20 per share, raising $21 million in gross proceeds. The company intends to use the net proceeds for general corporate purposes and to advance the development and construction of the Mojave Groundwater Bank Project.
Erie Indemnity reported Q3 2026 net income of $182.0 million, or $3.48 per diluted share, compared to $182.9 million in the prior year period. Management fee revenue from policy issuance and renewal services grew 2.6% to $856.3 million, while operating income saw a slight decrease of 0.7% due to higher agent incentive compensation and technology infrastructure costs.
CervoMed announced the publication of peer-reviewed results from its Phase 2b RewinD-LB clinical trial of neflamapimod in dementia with Lewy bodies (DLB). While the trial did not meet its primary endpoint in the full population, data showed a statistically significant increase in right basal forebrain volume and greater clinical benefit in patients without Alzheimer’s disease co-pathology.
For the nine months ended September 30, 2026, Restaurant Brands International LP reported a significant increase in net income to $1,814 million compared to $920 million in the prior year, driven by higher revenues and a substantial income tax benefit. Total revenues grew to $7,309 million, while the company successfully transitioned away from discontinued operations which had impacted the 2025 results.
TheRealReal reported a significant turnaround for the third quarter of 2026, achieving a net income of $16.0 million compared to a net loss of $54.1 million in the prior year period. Total revenue grew 18.7% year-over-year to $206.1 million, driven by strong performance in consignment and shipping services revenue.
Arthur J. Gallagher & Co. reported third quarter 2026 financial results, featuring total reported revenues of $3.93 billion and net earnings of $406 million. The company's combined Brokerage and Risk Management segments showed strong performance, with adjusted diluted net earnings per share rising to $3.00 from $2.31 in the prior year period.
Term
3 years
“We delivered another excellent quarter! Our combined Brokerage and Risk Management segments delivered revenue growth”
Wabash National reported a net loss of $20.7 million for the third quarter of 2026, a significant decline from a net income of $40.0 million in the prior year period. For the nine months ended September 30, 2026, the company recorded a net loss of $88.8 million compared to a net income of $261.3 million in 2025, primarily driven by higher costs of sales and a substantial decrease in operating income.
The Hanover Insurance Group reported net income of $172.6 million for the third quarter of 2026, a slight decrease from $178.7 million in the prior year period. Total revenues grew to $1.74 billion, driven by higher premiums and net investment income, while the company experienced a significant increase in unrealized losses on its investment portfolio during the quarter.
Mohawk Industries reported Q3 2026 net sales of $2.8 billion, up 1% year-over-year, and net earnings of $163 million. The company also announced a new $500 million share repurchase program authorized by the Board of Directors.
“We delivered a solid third quarter in a weak demand environment. We grew net sales as we executed price increases in response to rising inflation, we offset inflation with price, mix and productivity, and we are efficiently converting our earnings to strong cash flow.”
Invesco Mortgage Capital Inc. reported a net loss of $0.92 per common share for Q3 2026, as book value declined 16.1% to $6.74 due to tightening financial conditions and wider Agency RMBS spreads. Despite the market volatility, the company maintained a $8.0 billion investment portfolio and a strong liquidity position of $401.3 million in unrestricted cash and unencumbered investments.
Term
Q3 2026
“Economic growth remained resilient during the third quarter, but financial conditions tightened as investors increasingly priced in additional Federal Reserve rate hikes. Short-term Treasury yields rose on expectations for further monetary policy tightening, while longer-term yields increased on stronger growth expectations and concerns over elevated fiscal deficits and Treasury supply.”
Kevin Collins, Chief Executive Officer
“Our outlook for both Agency RMBS and Agency CMBS remains constructive. While uncertainty surrounding inflation, monetary policy, and geopolitical developments remains elevated, recent spread widening has enhanced the relative value and prospective return potential of both sectors.”
Eastman Chemical reported 3Q 2026 sales of $2.39 billion, an 8% increase year-over-year driven primarily by higher selling prices. The company delivered adjusted EPS of $1.84 and is on track to implement $500 million in price increases for the full year to offset rising raw material and distribution costs.
Term
3Q2026
“Eastman delivered solid results amid ongoing global macroeconomic uncertainty and escalation of the Middle East conflict. Input costs continued to elevate, and the Eastman team successfully implemented higher sequential price increases in our specialties.”
Ingersoll Rand reported third quarter 2026 results with revenue of $2.07 billion, up 6% year-over-year, and organic orders growth of 18%. The company achieved a reported net income of $670 million ($1.73 per share) and generated strong free cash flow of $623 million, supported by robust demand in its Industrial Technologies and Services segment.
Term
Q3 2026
“We delivered strong organic orders growth and revenue performance in the third quarter, reflecting an improved demand environment and continued execution by our teams. We saw healthy short-to-medium cycle and long cycle business activity across our geographies and end markets, and IRX continues to be a key differentiator with our teams remaining focused on controlling what we can control.”
Vicente Reynal, chairman and chief executive officer
For the thirty-nine weeks ended September 24, 2026, Floor & Decor reported net sales of $3.62 billion, a slight increase from $3.55 billion in the prior year period. Operating income grew to $254.4 million compared to $218.1 million, driven by improved gross profit margins despite macroeconomic headwinds like high interest rates and weak home sales.
For the nine months ended September 30, 2026, Mondelēz International reported net revenues of $29.4 billion and net earnings attributable to the company of $3.4 billion, a significant increase from $1.8 billion in the prior year. The company maintained a strong balance sheet with $71.8 billion in total assets and returned capital to shareholders through $1.95 billion in cash dividends and $881 million in stock repurchases during the period.
Pinterest, Inc. filed its 10-Q for the period ending late 2026, reporting 500,526,454 Class A and 72,981,386 Class B shares outstanding as of October 23, 2026. The company identified key risks including global economic uncertainty, its ability to scale monetization efforts, and the integration of artificial intelligence into its platform.
West Pharmaceutical Services reported net sales of $874.5 million for the third quarter of 2026, a 8.7% increase over the prior year. The company recognized a $55.7 million pre-tax gain from the sale of its SmartDose® 3.5mL On-Body Delivery System to AbbVie, contributing to a significant increase in net income to $214.0 million for the quarter.
Universal Insurance Holdings, Inc. reported a net income of $52.5 million for the third quarter of 2026, up from $39.8 million in the prior year period. Total revenues increased to $439.3 million, driven by higher net premiums earned and investment income, while the company maintained a strong liquidity position with total assets of $3.18 billion.
The RealReal reported record third quarter 2026 results with revenue increasing 19% year-over-year to $206 million and GMV growing 23% to $642 million. The company achieved GAAP net income of $16 million, a significant improvement from a $54 million loss in the prior year, and raised its full-year 2026 outlook.
Term
Q3 2026
“Q3 was another record quarter for The RealReal, with quarterly all-time highs in GMV, revenue and orders, with our strongest quarterly order growth since 2022, up 15% versus last year.”
Rati Levesque, CEO of The RealReal
“Underlying those results is a fundamental change in how people shop for luxury fashion, and our purpose-built platform is helping to drive it. Customers increasingly start their journey with us and engage well beyond the transaction, to discover what to buy, to track what they own, and to decide when to sell.”